ARYA Sciences Acquisition Corp II (ARYB) Stock Price, News & Analysis

Company Overview

ARYA Sciences Acquisition Corp II intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry in the United States and other developed countries. The company was founded in 2020 and is based in New York, New York.

Key Stats

• Today's Range: $10.00 to $10.14
• 50-Day Range: $9.95 to $10.34
• 52-Week Range: $9.90 to $13.94
• Volume: 20,048 shs
• Average Volume: 89,531 shs
• Market Capitalization: $193.79 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ARYB Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of ARYA Sciences Acquisition Corp II own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ARYA Sciences Acquisition Corp II investors own include Piper Sandler Companies (PIPR), AIkido Pharma (AIKI), Adverum Biotechnologies (ADVM), Adobe (ADBE), Accenture (ACN), Albertsons Companies (ACI) and Achieve Life Sciences (ACHV).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: Pharmaceutical Preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:ARYB
• CIK: N/A
• Web: N/A
• Phone: 212 284 2300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 19,187,000
• Free Float: N/A
• Market Cap: $193.79 million
• Optionable: Not Optionable
• Beta: N/A